Skip to content
Open access

CSK-DDI: Compensating Structural Incompleteness with Knowledge Graph World Knowledge for Drug-Drug Interaction Modeling.

Oct 2026 · Bioinformatics · 0 citations
Medicine

TL;DR

CSK-DDI is a multimodal framework that jointly encodes motif-level chemical patterns, molecular graph topology, and biomedical knowledge graph context as complementary drug representations and incorporates a cold-start-oriented representation enhancement strategy to improve robustness under sparse conditions.

Abstract

MOTIVATION Drug-drug interaction (DDI) prediction is critical for drug safety, yet existing methods suffer from structural incompleteness in drug representation. Motif and molecular graph encodings capture local substructures and global topology but remain confined to the closed structural space of individual molecules, lacking cross-entity and contextual information and leading to limited generalization, especially in cold-start scenarios. To address this issue, we propose CSK-DDI, a multimodal framework that jointly encodes motif-level chemical patterns, molecular graph topology, and biomedical knowledge graph context as complementary drug representations. The KG encodes drugs' contextual positions and relational semantics through multi-entity and multi-relation connections, providing global cross-entity and cross-semantic information that complements structural representations. The resulting fusion captures local chemical patterns, global topology, and biomedical context in a unified embedding. RESULTS CSK-DDI employs a cross-attention mechanism to enable multi-view interaction among motif, molecular graph, and knowledge graph representations, producing unified structure-aware and context-aware drug embeddings. To improve robustness under sparse conditions, the model further incorporates a cold-start-oriented representation enhancement strategy. Experiments on benchmark datasets demonstrate consistent improvements over state-of-the-art methods, with particularly notable gains in cold-start scenarios. AVAILABILITY Source code and data are available at https://github.com/cgwcbz2/CSK-DDI and on Zenodo at https://doi.org/10.5281/zenodo.21415769. SUPPLEMENTARY INFORMATION Supplementary data are available at Bioinformatics online.

Read PDF

Similar papers

Open access Oct 2026

MEGH-DDI: MolT5-driven edge-aware graph learning with Hop2Token representation for drug–drug interaction prediction

Drug-drug interactions (DDIs) are critical in pharmacology, as synergistic or antagonistic effects between co-administered drugs can enhance therapeutic outcomes or cause toxicity, posing major challenges for drug safety assessment and new drug development. Current molecular representation methods often fail to capture...

Li Zhou, Yun Zuo, Wen-Ying He et al. · 0 citations
Sep 2026

Dual-Channel Structure-Aware Transformer Framework for Drug-Drug Interaction Prediction.

Accurate prediction of drug-drug interactions (DDIs) is crucial for ensuring drug safety and supporting pharmaceutical development. Existing methods still face challenges in jointly modeling molecular structural information and biomedical semantic contexts. To address this issue, we propose DSAT-DDI, a Dual-channel Str...

Yu Li, Jia-Ming Liu, Yue-Chao Li et al. · 0 citations
Open access Sep 2026

GAT-MG-ECF: A Dependency Graph-Attention Extension of Multi-Granularity Entity–Context Fusion for Drug–Drug Interaction Extraction

Harmful drug–drug interactions (DDIs) are a common, preventable cause of hospitalizations, adverse drug events, and mistaken treatment decisions, and extracting them from the biomedical literature supports online pharmacovigilance and clinical decision support. Prior extractors fuse several views of a sentence from a p...

Hiba Chanaa, E. Nfaoui, Loqman Chakir · 0 citations
Oct 2026

HTF-DTI: Hypergraph-Based high-low order topological fusion for drug-target interaction prediction.

OBJECTIVE Accurate drug-target interaction (DTI) prediction can accelerate candidate prioritization in drug discovery and repurposing. However, existing graph-based methods may inadequately integrate high-order neighborhood dependencies with the low-order drug-target topology and often rely on shallow feature fusion fo...

Yuezhongyi Sun, Xu-Feng Wang, Deng-Ju Yao · 0 citations
#artificial intelligence Open access Oct 2026

HierDTA: Hierarchical Structure-Aware Representation Learning for Drug–Target Affinity Prediction

Drug–target affinity (DTA) prediction plays an important role in computer-aided drug discovery, where reliable computational models can help prioritize compound–protein pairs before experimental validation. A key challenge in DTA prediction is to effectively mine multilevel molecular information from drug structures wh...

Huang-Chao Xu, Bao-Hua Zhang, Qian Liu et al. · 0 citations
Oct 2026

MMB-DTI: A Multimodal State Space Framework with Bidirectional Cross-Attention for Drug-Target Interaction Prediction.

Comprehensive evaluations across six benchmark datasets demonstrate that MMB-DTI achieves highly competitive predictive performance, significantly outperforming state-of-the-art baselines, and highlights that coupling linear-time state space modeling with topological complementarity yields a robust and discriminative p...

Fang Fang, Jin-Jin Li, Cheng-Ye Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.